Searchable abstracts of presentations at key conferences in endocrinology

ea0059p137 | Neuroendocrinology and pituitary | SFEBES2018

Safety of prescribing for inpatients with cranial diabetes insipidus (CDI): a Southwest Peninsula Audit

Edeghere Simon , Morton Claire , Rogers Sue , Babiker Tarig , Elzain Yamin , Brooke Antonia , Network Peninsula Endocrine

Cranial Diabetes Insipidus (CDI) is associated with significant polyuria and is treated with desmopressin. Inappropriate or missed treatment can result in significant electrolyte imbalance and potential harm. A recent UK survey of Endocrinologists reported 55% had concerns about knowledge in their trust, 39% felt they had observed patients come to harm. Patients not receiving desmopressin have been associated with death, leading to an NHS England (NHSE) safety alert in 2016. W...

ea0059p197 | Reproduction | SFEBES2018

Reproductive Life Course Project: Preliminary data from UK Turner Syndrome Pregnancy audit

Burt Elizabeth , Pimblett Antoinette Cameron , Donohoe Mollie , Calanchini Matilde , Morton Claire , Smyth Arlene , Brooke Antoinia , Gleeson Helena , Simpson Helen , Turner Helen E , Davies Melanie C , Conway Gerard S

Turner Syndrome (TS) affects 1:2500 females and is caused by the partial or complete loss of one X chromosome. About 80% of women with TS experience primary amenorrhea and therefore the only option for fertility treatment is ovum donation (OD). The remaining 20% may have the opportunity for a spontaneous pregnancy. Pregnancy in women with TS has been associated with excess obstetric risk such as miscarriage and hypertension. Maternal mortality has been estimated to be 2% risk ...